Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
not indicated publication
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Remarks:
An OECD guideline does not exist for this type of study

Data source

Reference
Reference Type:
publication
Title:
Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers
Author:
Feng Shi*, Yingying Zhao*, Caleb Kesse Firempong and Ximing Xu
Year:
2016
Bibliographic source:
PHARMACEUTICAL BIOLOGY, 2016 VOL. 54, NO. 10, 2320–2328 http://dx.doi.org/10.3109/13880209.2016.1155630

Materials and methods

Objective of study:
toxicokinetics
Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
Linalool was suspended in 0.5% carboxymethylcellulose and applied via oral gavage to SD rats. Blood was drawn at several timepoints to prepare plasma. The concentration of Linalool in the plasma was analysed using a HPLC-UV method. The toxicokinetic parameters were calculated using BAPP 2.3 software package.
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Linalool
EC Number:
201-134-4
EC Name:
Linalool
Cas Number:
78-70-6
Molecular formula:
C10H18O
IUPAC Name:
3,7-dimethylocta-1,6-dien-3-ol
Details on test material:
- Name of test material (as cited in study report): Linalool
- Substance type: Unsaturated racemic monoterpene alcohol
Specific details on test material used for the study:
Linalool (98%) from J&K Scientific Ltd. (Beijing, China)
Radiolabelling:
no

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on species / strain selection:
Healthy male Sprague-Dawley rats (weight 300 ± 20 g) were obtained from Laboratory Animal Center of Jiangsu University (Jiangsu, China).
Sex:
male
Details on test animals or test system and environmental conditions:
The rats were fed with standard food pellets and maintained under standard laboratory conditions with a dark/light cycle of 12 h. All rats were fasted overnight before the experiments, but allowed access to water ad libitum. The use and care protocols of rats were reviewed and approved by the Ethic Committee of Jiangsu University.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Details on exposure:
Six male Sprague-Dawley rats received Linalool as a suspension in 0.5% (w/v) sodium carboxymethylcellulose at a dose level of 300 mg/kg bw.
Duration and frequency of treatment / exposure:
single dose
Doses / concentrations
Dose / conc.:
300 mg/kg bw (total dose)
No. of animals per sex per dose / concentration:
6
Control animals:
no
Positive control reference chemical:
No details given
Details on study design:
Six healthy male Sprague-Dawley rats (weighing approximately 300 g) were given Linalool via oral gavage using 0.5% CMC as vehicle.
Details on dosing and sampling:
After oral administration, blood samples (0.6 mL) were collecated at several time points (5, 10, 15, 20, 30, 40, 50, 60, 120, 180, 240, 300, 360 and 480 min) into heparinized centrifuge tubes. Plasma was prepared and analysed for Linalool using a HPLC-UV method. The HPLC apparatus included a pump (LC-10ADVP; Shimadzu), an UV detector (SPD-20A; Shimadzu) and a Symmetric C18 column (5 microm, 4.6x150 mm) at a detection wavelength of 210nm at 30 °C, and the injection volume was 20 microL. The mobile phase consisted of acetonitrile-water (47:53) at a flow rate of 1.0mL/min.
Statistics:
n.a.

Results and discussion

Toxicokinetic / pharmacokinetic studies

Details on absorption:
not investigated
Details on distribution in tissues:
not investigated
Details on excretion:
not investigated
Toxicokinetic parametersopen allclose all
Key result
Toxicokinetic parameters:
AUC: 76003.40 ng/min/mL
Key result
Toxicokinetic parameters:
Cmax: 1915.45 ng/mL
Key result
Toxicokinetic parameters:
Tmax: 40 min
Key result
Toxicokinetic parameters:
half-life 1st: 44.72 min

Metabolite characterisation studies

Metabolites identified:
not measured

Enzymatic activity

Enzymatic activity measured:
not measured

Bioaccessibility (or Bioavailability)

Bioaccessibility (or Bioavailability) testing results:
not investigated

Applicant's summary and conclusion

Conclusions:
Linalool is rapidly taken up upon oral bolus administration even at relatively high doses with the Cmax being observed already after 40 min. Linalool is rapidly eliminated from plasma with a half-life of approximately 45 min. Linalool could not be detected anymore in the plasma after 240 min.
Executive summary:

Six healthy male Sprague-Dawley rats (weighing approximately 300 g) were given Linalool via oral gavage using 0.5% CMC as vehicle. After oral administration, blood samples (0.6 mL) were collected at several time points into heparinized centrifuge tubes: 5, 10, 15, 20, 30, 40, 50, 60, 120, 180, 240, 300, 360 and 480 min. Plasma was prepared and analysed for Linalool using a HPLC-UV method. The HPLC apparatus included a pump (LC-10ADVP; Shimadzu), an UV detector (SPD-20A; Shimadzu) and a Symmetric C18 column (5 microm, 4.6 x 150 mm) at a detection wavelength of 210 nm at 30 °C, and the injection volume was 20 µL. The mobile phase consisted of acetonitrile-water (47:53) at a flow rate of 1.0mL/min. Toxicokinetic parameters were investigated using BAPP 2.3 pharmacokinetic software package (supplied by the Center of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University).


Linalool is rapidly taken up upon oral bolus administration even at relatively high doses with the Cmax (1915.45 ng/mL) being observed already after 40 min. Linalool is rapidly eliminated from plasma with a half-life of approximately 45 min. Linalool could not be detected anymore in the plasma after 240 min. The AUC(0 -t) was 76003.40 ng/min/mL.